Truist Financial’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.31M | Buy |
362,037
+26,608
| +8% | +$170K | ﹤0.01% | 1200 |
|
|
2025
Q1 | $1.63M | Buy |
335,429
+250,236
| +294% | +$1.22M | ﹤0.01% | 1308 |
|
|
2024
Q4 | $814K | Sell |
85,193
-59,003
| -41% | -$564K | ﹤0.01% | 1634 |
|
|
2024
Q3 | $1.2M | Buy |
144,196
+12,670
| +10% | +$106K | ﹤0.01% | 1432 |
|
|
2024
Q2 | $897K | Buy |
131,526
+14,360
| +12% | +$97.9K | ﹤0.01% | 1658 |
|
|
2024
Q1 | $296K | Buy |
117,166
+3,500
| +3% | +$8.86K | ﹤0.01% | 2287 |
|
|
2023
Q4 | $273K | Buy |
113,666
+3,595
| +3% | +$8.63K | ﹤0.01% | 2353 |
|
|
2023
Q3 | $374K | Buy |
+110,071
| New | +$374K | ﹤0.01% | 2080 |
|
|
2021
Q2 | – | Sell |
-7,059
| Closed | -$656K | – | 2693 |
|
|
2021
Q1 | $656K | Buy |
7,059
+1,745
| +33% | +$162K | ﹤0.01% | 1814 |
|
|
2020
Q4 | $476K | Buy |
5,314
+1,188
| +29% | +$106K | ﹤0.01% | 1856 |
|
|
2020
Q3 | $426K | Buy |
+4,126
| New | +$426K | ﹤0.01% | 1784 |
|